NCT07107269

Brief Summary

The gut microbiome has been shown to impact various facets of human health, including mental health. Studies have shown that populations with more agrarian lifestyles tend to have fewer chronic diseases and mental health issues than industrialized populations. A possible factor in these differences is the loss of co-evolved gut microbial taxa that has occurred with Westernization. This hypothesis, termed "Old Friends Hypothesis" suggests that the loss of certain gut microbes leads to immune dysregulation and increased chronic inflammation that contributes to development of cancers, cardiometabolic diseases and even neuroinflammation that can lead to negative behavioral and mental health outcomes. Other studies have shown that increasing the intake of plant foods may help increase diversity of the microbes in the gut and that this increased diversity could lead to better health outcomes in humans. The investigators propose to evaluate daily consumption of a drink consisting of a high diversity of plants (30 plant species) for four weeks on the diversity of the gut microbiome, biological signatures of inflammation, quality of life, sleep quality, and PTSD symptoms among persons with a diagnosis of PTSD. The investigators hypothesize that four weeks of daily consumption of this high plant diversity beverage (30 plant species) will increase gut microbiome ɑ-diversity, reduce markers of systemic inflammation, and improve PTSD symptom severity relative to daily consumption of a beverage containing only three plant species.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
40

participants targeted

Target at P25-P50 for not_applicable

Timeline
0mo left

Started Jun 2025

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress96%
Jun 2025Jul 2026

Study Start

First participant enrolled

June 25, 2025

Completed
28 days until next milestone

First Submitted

Initial submission to the registry

July 23, 2025

Completed
14 days until next milestone

First Posted

Study publicly available on registry

August 6, 2025

Completed
11 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 30, 2026

Expected
1 day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2026

Last Updated

August 6, 2025

Status Verified

July 1, 2025

Enrollment Period

1 year

First QC Date

July 23, 2025

Last Update Submit

July 30, 2025

Conditions

Keywords

PTSDPost Traumatic Stress DisorderHighly Diverse Fruit and Vegetable DrinkPTSD and microbiome

Outcome Measures

Primary Outcomes (4)

  • Changes in self-assessed severity of post-traumatic stress disorder (PTSD) symptoms

    PTSD Checklist for DSM-5 or the PCL-5 questionnaire. The PCL-5 is a 20-item self-report measure that assesses the 20 DSM-5 symptoms of PTSD. The PCL-5 has a variety of purposes, including: Monitoring symptom change during and after treatment Screening individuals for PTSD Making a provisional PTSD diagnosis A higher score on the PCL-5 indicates a greater level of distress and impairment associated with PTSD symptoms. The total score ranges from 0 to 80, with higher scores reflecting a more severe symptomatology. A total score of 32 or above suggests the presence of clinically significant PTSD symptoms, which may require further assessment and treatment.

    From enrollment to the end of the 4-week intervention period.

  • Gut Microbiota Richness

    Microbiota richness will be determined by the number of amplicon sequence variants (actual or estimated) in a fecal sample.

    From enrollment to the end of the 4-week intervention period.

  • Gut microbiota diversity

    The Shannon-Wiener index will be applied to 16s rRNA amplicon sequence variants to determine microbial community diversity within a fecal sample.

    From enrollment to the end of the 4-week intervention period.

  • C-reactive protein in plasma

    CRP, or C-reactive protein, is a substance produced by the liver in response to inflammation in the body. It is commonly measured in blood using a high sensitivity ELISA test to assess general inflammation levels, helping to identify underlying health issues such as infections, tissue injury, or chronic inflammatory diseases. Elevated levels of CRP are associated with PTSD.

    From enrollment to the end of the 4-week intervention period.

Secondary Outcomes (2)

  • Seated Blood Pressure

    From enrollment to the end of the 4-week intervention period.

  • Changes in T-cell populations

    From enrollment to the end of the 4-week intervention period.

Study Arms (2)

High plant diversity intervention

EXPERIMENTAL

30 different vegetables as a 4 oz blended beverage in a mylar pouch.

Other: Functional Food intervention

Low plant diversity intervention group

EXPERIMENTAL

3 vegetable blend as a 4 oz blended beverage in a mylar pouch.

Other: Low plant diversity beverage

Interventions

Blended drink made from 3 organic vegetables (Power Greens mix)

Low plant diversity intervention group

This is a 4oz shot made from 30 different organic vegetables and packaged in mylar pouches.

High plant diversity intervention

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Healthy adults (age 18-65) with a diagnosis of PTSD and a BMI \<35. Participants should be willing to follow the study protocols and attend all clinic visits.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Food and Nutrition Clinical Research Lab - Colorado State University

Fort Collins, Colorado, 80523, United States

RECRUITING

MeSH Terms

Conditions

Combat DisordersStress Disorders, Post-Traumatic

Condition Hierarchy (Ancestors)

Stress Disorders, TraumaticTrauma and Stressor Related DisordersMental Disorders

Study Officials

  • Tiffany Weir, PhD

    Colorado State University

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Jenny Whittington, MS

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Model Details: Randomized, double-blinded, parallel arm, controlled diet intervention
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

July 23, 2025

First Posted

August 6, 2025

Study Start

June 25, 2025

Primary Completion (Estimated)

June 30, 2026

Study Completion (Estimated)

July 1, 2026

Last Updated

August 6, 2025

Record last verified: 2025-07

Data Sharing

IPD Sharing
Will not share

Locations